Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin
PLOS Pathogens · 09.09.2024 · 20 (9) · e1012541
DOI: 10.1371/journal.ppat.1012541 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 09.09.2024. Verfasst von Guanru Qian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery & Hernia and Abdominal Wall Surgery, the First Hospital, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Colitis, Cadherins, Intestinal Mucosa, Dextran Sulfate. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Program from the Science and Technology Agency of Liaoning Province, China, The Applied Basic Research Program from Science and Technology Agency of Liaoning Province.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is an immune system disorder primarily characterized by colitis, the exact etiology of which remains unclear. Traditional treatment approaches currently yield limited efficacy and are associated with significant side effects. Extensive research has indicated the potent therapeutic effects of probiotics, particularly Lactobacillus strains, in managing colitis. However, the mechanisms through which Lactobacillus strains ameliorate colitis require further exploration. In our study, we selected Lactobacillus gasseri ATCC33323 from the intestinal microbiota to elucidate the specific mechanisms involved in modulation of colitis. Experimental findings in a DSS-induced colitis mouse model revealed that L . gasseri ATCC33323 significantly improved physiological damage in colitic mice, reduced the severity of colonic inflammation, decreased the production of inflammatory factors, and preserved the integrity of the intestinal epithelial structure and function. It also maintained the expression and localization of adhesive proteins while improving intestinal barrier permeability and restoring dysbiosis in the gut microbiota. E-cadherin, a critical adhesive protein, plays a pivotal role in this protective mechanism. Knocking down E-cadherin expression within the mouse intestinal tract significantly attenuated the ability of L . gasseri ATCC33323 to regulate colitis, thus confirming its protective role through E-cadherin. Finally, transcriptional analysis and in vitro experiments revealed that L . gasseri ATCC33323 regulates CDH1 transcription by affecting NR1I3, thereby promoting E-cadherin expression. These findings contribute to a better understanding of the specific mechanisms by which Lactobacillus strains alleviate colitis, offering new insights for the potential use of L . gasseri as an alternative therapy for IBD, particularly in dietary supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery & Hernia and Abdominal Wall Surgery, the First Hospital, China Medical University, Shenyang, China.
- Department of Shenyang Medical Nutrition Clinical Medical Research Center, Shenyang, China.
ORCID-Profile: Jianping Zhou
Förderung
- Applied Basic Research Program from the Science and Technology Agency of Liaoning Province, China
- The Applied Basic Research Program from Science and Technology Agency of Liaoning Province
Zitieren
APA
Qian, G., Zang, H., Tang, J., Zhang, H., Yu, J., Jia, H., Zhang, X., & Zhou, J. (2024). Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin. PLOS Pathogens, 20(9), e1012541. https://doi.org/10.1371/journal.ppat.1012541
Vancouver
Qian G, Zang H, Tang J, Zhang H, Yu J, Jia H, et al. Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin. PLOS Pathogens. 2024;20(9):e1012541. doi:10.1371/journal.ppat.1012541
BibTeX
@article{Qian2024,
author = {Qian, Guanru and Zang, Hui and Tang, Jingtong and Zhang, Hao and Yu, Jiankang and Jia, Huibiao and Zhang, Xinzhuang and Zhou, Jianping},
title = {Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin},
journal = {PLOS Pathogens},
year = {2024},
volume = {20},
number = {9},
pages = {e1012541},
doi = {10.1371/journal.ppat.1012541}
}
EUVIMED